Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P KIM

Showing results (1181-1190 of 1,500) with videos related to

Pageof 150
Sort By:
Urologic Oncology|December 3, 2014
The burden of skeletal-related events in patients with prostate cancer and bone metastasisFlorian Roghmann, Carina Antczak, Rana R McKay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic TumorsAslamuzzaman Kazi, Shengyan Xiang, Hua Yang, et al.
JCO Precision Oncology|January 15, 2026
Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic AdenocarcinomaAdriana C Gamboa, Kever A Lewis, Laura R Prakash, et al.
The Journal of Clinical Investigation|April 25, 2024
Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancerXiaochao Tan, Shike Wang, Guan-Yu Xiao, et al.
International Journal of Cancer|February 7, 1997
Establishment and characterization of human gastric carcinoma cell linesJ G Park, H K Yang, W H Kim, et al.
JAMA Surgery|September 6, 2023
Opioid-Free Discharge After Pancreatic Resection Through a Learning Health System ParadigmArtem Boyev, Anish J Jain, Timothy E Newhook, et al.
Annals of Surgical Oncology|June 28, 2019
Inpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery PatientsTimothy E Newhook, Whitney L Dewhurst, Timothy J Vreeland, et al.
Cancer|July 20, 2016
National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?Brandon A Mahal, Yu-Wei Chen, Vinayak Muralidhar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Identification and Validation of T-cell Receptors Targeting <i>RAS</i> Hotspot Mutations in Human Cancers for Use in Cell-based ImmunotherapyNoam Levin, Biman C Paria, Nolan R Vale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United StatesB A Mahal, Y-W Chen, V Muralidhar, et al.
Pageof 150

Showing results (1181-1190 of 1,500) with videos related to

Sort By:
Pageof 150
Urologic Oncology|December 3, 2014
The burden of skeletal-related events in patients with prostate cancer and bone metastasisFlorian Roghmann, Carina Antczak, Rana R McKay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic TumorsAslamuzzaman Kazi, Shengyan Xiang, Hua Yang, et al.
JCO Precision Oncology|January 15, 2026
Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic AdenocarcinomaAdriana C Gamboa, Kever A Lewis, Laura R Prakash, et al.
The Journal of Clinical Investigation|April 25, 2024
Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancerXiaochao Tan, Shike Wang, Guan-Yu Xiao, et al.
International Journal of Cancer|February 7, 1997
Establishment and characterization of human gastric carcinoma cell linesJ G Park, H K Yang, W H Kim, et al.
JAMA Surgery|September 6, 2023
Opioid-Free Discharge After Pancreatic Resection Through a Learning Health System ParadigmArtem Boyev, Anish J Jain, Timothy E Newhook, et al.
Annals of Surgical Oncology|June 28, 2019
Inpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery PatientsTimothy E Newhook, Whitney L Dewhurst, Timothy J Vreeland, et al.
Cancer|July 20, 2016
National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?Brandon A Mahal, Yu-Wei Chen, Vinayak Muralidhar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Identification and Validation of T-cell Receptors Targeting <i>RAS</i> Hotspot Mutations in Human Cancers for Use in Cell-based ImmunotherapyNoam Levin, Biman C Paria, Nolan R Vale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United StatesB A Mahal, Y-W Chen, V Muralidhar, et al.
Pageof 150